Note: Ingredients listed on restricted chemical lists
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=0,1-<1 >=5% >=5% >=5% >=0,1%
General Information
Version
1.0
Revision date
2025-05-06
Product name
ULTIMATE RUDELIM, 400ML
1.2.1 Relevant identified uses
Adhesives Professional use product
1.2.2. Uses advised against
May only be used by trained personnel on use
Emergency telephone
+45 7932 3232, +45 7556 9710, +49 (0)6132 84463, +45 82121212
Icons in SDS
Company Information
company name
Würth Danmark A/S
e-mail address of the competent person responsible for the Safety Data Sheet
contact@wurth.com.mk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breath- ing difficulties if inhaled.
Prevention
P261 Avoid breathing vapours. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
4,4'-Diphenylmethane diisocyanate
Additional information
"As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome).
